SEC Form 3 · accession 0001209191-15-032493
Aegerion Pharmaceuticals, Inc. · AEGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mary Weger
Officer — Chief Performance Officer
Period of report
Mar 29, 2015
Accepted (ET)
Apr 3, 2015 · 7:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001338042
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 3,038 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $15.95 | holding | — | — | — | Dec 31, 2014 | Jan 23, 2022 | Common Stock | 45,000 | — | D |
| Stock Option (right to buy)F1 | $16.28 | holding | — | — | — | — | Jan 3, 2022 | Common Stock | 75,000 | — | D |
| Stock Option (right to buy)F2 | $22.35 | holding | — | — | — | — | Nov 1, 2022 | Common Stock | 40,000 | — | D |
| Stock Option (right to buy)F3 | $39.02 | holding | — | — | — | — | Apr 1, 2023 | Common Stock | 20,000 | — | D |
| Stock Option (right to buy)F4 | $47.11 | holding | — | — | — | — | Apr 1, 2024 | Common Stock | 13,000 | — | D |
| Stock Option (right to buy)F5 | $20.93 | holding | — | — | — | — | Nov 3, 2024 | Common Stock | 40,000 | — | D |
Explanation of responses
- F1The shares of common stock underlying this option vest and become exercisable in equal monthly installments over 48 months from date of grant until January 3, 2016.
- F2The shares of common stock underlying this option vest and become exercisable in equal monthly installments over 48 months from date of grant until November 1, 2016.
- F3The shares of common stock underlying this option vest and become exercisable in equal monthly installments over 48 months from date of grant until April 1, 2017.
- F425% of the shares of common stock underlying this stock option award vested on April 1, 2015. The remaining 75% of the shares of common stock underlying this stock option award will vest in equal monthly installments through April 1, 2018.
- F525% of the shares of common stock underlying this stock option award will vest on November 3, 2015. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through November 3, 2018